Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab
‘Where the product in question is a life-saving drug, the Court has to err in favour of public interest’, said the bench The Delhi High Court on Monday cleared the…
Biosimilar Drug Companies caught candid trying to skirt around Conditions for Marketing
New Delhi : Renowned consumer activists have cut short attempts of biosimilar drug companies to take shortcut for marketing medicines. The makers of this genre of medicines are batting for…






